Federal Official Gazette
No updates.
ANS news
ANS releases beneficiary movement data for September
The sector recorded 53.2 million users in medical care plans and 34.9 million in exclusively dental plans
ANS grants special portability to customers of two operators
Beneficiaries of the Associação Valeparaibana de Assistência Médica Policial have 60 more days to switch plans without serving a waiting period
Open public consultations
- CP 163. Its purpose is to receive input on the proposed updates to the List of Health Procedures and Events (Rol), specifically on the preliminary recommendation of non-incorporation for the technologies covered by UAT No. 171 – Inclisiran, UAT No. 175 – Lebrikizumab and UAT No. 176 – Momelotinib. Deadline: Nov 5, 2025 to Nov 24, 2025
Scheduled public hearings
- Public Hearing No. 61, Collection of input on the preliminary recommendation of non-incorporation for the following technologies:
(i) UAT 171 – Inclisiran for the treatment of primary hypercholesterolemia or mixed dyslipidemia;
(ii) UAT 175 – Lebrikizumab for the treatment of adult patients with severe atopic dermatitis who have failed, are intolerant to or have a contraindication to cyclosporine; and
(iii) UAT 176 – Momelotinib for the treatment of intermediate- and high-risk myelofibrosis.
Date: November 19, 2025, from 9 a.m. to 1 p.m.
Open public calls for input
There are no open public calls for input.
Open public calls
No updates.
Other news
Ipsos survey shows that physicians have a negative perception of health plans
Source: migalhas.com.br · read the full article
New resolution on self-managed operators may contribute to portfolio rebalancing and sustainability
Source: futurodasaude.com.br · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.